Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Erythropoietin (EPO)
EPO | Red Blood Cell Stimulating Hormone
EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with Erythropoietin (EPO)?
Yes, BPC-157 and Erythropoietin (EPO) can generally be taken together. Different mechanisms; no known interactions.
Is BPC-157 and Erythropoietin (EPO) safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: carcinogenic risk. Monitor accordingly.
What are the interactions between BPC-157 and Erythropoietin (EPO)?
Different mechanisms; no known interactions. This assessment has 90% confidence and is based on documented research data.
How should I time BPC-157 and Erythropoietin (EPO)?
BPC-157 has a half-life of <30 minutes and Erythropoietin (EPO) has a half-life of 4-12 hours (IV), ~25 hours (SubQ). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.